NCT01891045

Brief Summary

Dropout represents one of the largest problems in substance abuse treatment. International and Nordic research show that only 20 - 40 % of substance abusers complete treatment as intended. At the same time, one of the most consistent factors of favourable post-treatment outcome is treatment completion. In spite of the serious and continuous challenge dropout represents the phenomena is not well understood and there is a need to explore more of the factors that influence dropout and how it can be counteracted. As also stated: "…effective methods for reducing the problem of dropouts from treatment is one more area in need of further research" (NOU 2003:4, s 77). For the general field of mental health one of the most important innovations involves providing therapists with patient feedback about their progress. The most well-established and widely researched feedback system is the Outcome Questionnaire (OQ-45.2). The system has been shown to improve treatment outcomes, including reduced treatment dropout and length of treatment, but the system is yet to be utilized with a substance abusing patient group. The aim of the present study is to examine the usefulness of OQ-45.2 with substance abusing patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

July 6, 2012

Completed
12 months until next milestone

First Posted

Study publicly available on registry

July 2, 2013

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
8.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 3, 2023

Completed
Last Updated

January 24, 2024

Status Verified

January 1, 2024

Enrollment Period

3.3 years

First QC Date

July 6, 2012

Last Update Submit

January 23, 2024

Conditions

Drug AddictionDrug Abuse

Keywords

PsychotherapyDrug addictionDrop-outOQ-45.2Clinical trialRandomized Controlled Trail

Outcome Measures

Primary Outcomes (1)

  • Drop-out from residential SUD treatment

    Exit reason from residential Substance Use Disorder treatment (Drop-out or completed as planned)

    Four years

Study Arms (3)

Control

NO INTERVENTION

Patients merely monitored on background variables to function as a baseline of comparison

Prediction

ACTIVE COMPARATOR

Patients randomized to this condition completes the OQ-45.2 weekly, but the reports are withheld from therapists and patients.

Behavioral: OQ-45.2 no feedback

Intervention

EXPERIMENTAL

Patients and therapists uses the feedback-system as intended, with real-time feedback to the therapist and full use of the suggested interventions

Behavioral: OQ-45.2

Interventions

OQ-45.2 no feedbackBEHAVIORAL

Completion of the OQ-45.2 before each session, but no feedback to therapists or patients

Prediction
OQ-45.2BEHAVIORAL

Completion of the OQ-45.2 with real-time feedback to the therapist and full use of the suggested interventions every week of the treatment program

Intervention

Eligibility Criteria

Age16 Years - 26 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Primary diagnosis of addiction, F10-19, using the International Classification of Diseases, admitted in 2011-2014 for treatment at the department of addiction treatment - youth, Oslo University Hospital

You may not qualify if:

  • Ongoing psychoses, severe language difficulties

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of addiction treatment- youth

Oslo, 0514, Norway

Location

Oslo University Hospital - Department of addiction treatment youth

Oslo, 0514, Norway

Location

Related Publications (2)

  • Amble I, Gude T, Stubdal S, Oktedalen T, Skjorten AM, Andersen BJ, Solbakken OA, Brorson HH, Arnevik E, Lambert MJ, Wampold BE. Psychometric properties of the outcome questionnaire-45.2: the Norwegian version in an international context. Psychother Res. 2014;24(4):504-13. doi: 10.1080/10503307.2013.849016. Epub 2013 Nov 5.

    PMID: 24188797RESULT

  • Brorson HH, Arnevik EA, Rand K. Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst. Subst Abuse. 2019 Aug 15;13:1178221819866181. doi: 10.1177/1178221819866181. eCollection 2019.

    PMID: 31452601RESULT

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

July 6, 2012

First Posted

July 2, 2013

Study Start

July 1, 2011

Primary Completion

November 1, 2014

Study Completion

January 3, 2023

Last Updated

January 24, 2024

Record last verified: 2024-01

Locations

NO(2)